Search
Axsome Therapeutics Inc
AXSMAdd to Watchlist
217.990USD
-16.650-7.10%
Close 07-31 16:00（ET）Quotes delayed by 15 min
11.22BMarket Cap
LossP/E TTM
Axsome Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Axsome Therapeutics Inc is 9.71, ranking 6 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -58.49, which is -82.58% below the recent high of -10.19 and -17.06% above the recent low of -68.46.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.